01.08.2023 | Case report
Bevacizumab/savolitinib/sintilimab
Gastrointestinal effects, oedema in both legs and lack of efficacy: case report
Erschienen in: Reactions Weekly | Ausgabe 1/2023
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event